<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: albert einstein</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Molecular fingerprint discovered that may improve outcomes for head and neck cancer patients</title>
   	 <description>Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening. The biomarker is considered particularly promising because it can detect the level of risk immediately following diagnosis. This discovery could become a component of a new test to guide how aggressively those with head and neck tumors should be treated. The findings were published online January 9 in the American Journal of Pathology.</description>
	  <link>http://medicalxpress.com/news/2012-01-molecular-fingerprint-outcomes-neck-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 23 Jan 2012 12:27:42 EST</pubDate>
	 <guid isPermaLink="false">news246544027</guid>
	 
</item>
<item>
     <title>TB vaccine candidate shows early promise in mice</title>
   	 <description>A potential vaccine against tuberculosis has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response. Once this first-line defense has been activated, it triggers the more specific immune response that can protect against future infections.</description>
	  <link>http://medicalxpress.com/news/2011-09-potential-vaccine-readies-immune-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 04 Sep 2011 13:00:39 EST</pubDate>
	 <guid isPermaLink="false">news234359473</guid>
	 
</item>
<item>
     <title>Psychiatrists failing to adequately monitor patients for metabolic side-effects of prescribed drugs</title>
   	 <description>(Medical Xpress) -- New research from the University of Leicester demonstrates that psychiatrists are not offering adequate checks for metabolic complications that are common in patients with mental ill health - especially those prescribed antipsychotic medication.</description>
	  <link>http://medicalxpress.com/news/2011-08-psychiatrists-adequately-patients-metabolic-side-effects.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 10 Aug 2011 03:40:03 EST</pubDate>
	 <guid isPermaLink="false">news232163249</guid>
	 
</item>
<item>
     <title>Treating obesity via brain glucose sensing</title>
   	 <description>The past two decades have witnessed an epidemic spread of obesity-related diseases in Western countries. Elucidating the biological mechanism that links overnutrition to obesity could prove crucial in reducing obesity levels. In the July 26 issue of PLoS Biology, Dr. Dongsheng Cai and his research team at Albert Einstein College of Medicine describe a pathway that directs the brain to sense the body's glucose dynamics, and they find that a defect of this glucose sensing process contributes to the development of obesity and related disease. Importantly, the team also found that correction of this defect can normalize the whole-body energy balance and treat obesity.</description>
	  <link>http://medicalxpress.com/news/2011-07-obesity-brain-glucose.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 26 Jul 2011 17:27:25 EST</pubDate>
	 <guid isPermaLink="false">news230919926</guid>
	 
</item>
<item>
     <title>PXR: A stepping stone from environmental chemical to cancer?</title>
   	 <description>Several chemicals that can accumulate to high levels in our body (for example BPA and some pesticides) have been recently linked to an increased risk of cancer and/or impaired responsiveness to anticancer drugs. A team of researchers, led by Sridhar Mani, at Albert Einstein College of Medicine, New York, has now identified a potential mechanistic link between environmental exposure to these foreign chemicals (xenogens) and cancer drug therapy response and survival.</description>
	  <link>http://medicalxpress.com/news/2011-07-pxr-stone-environmental-chemical-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 11 Jul 2011 12:53:42 EST</pubDate>
	 <guid isPermaLink="false">news229607612</guid>
	 
</item>


</channel>
</rss>
